BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 12102602)

  • 1. Multidrug resistance phenotype mediated by the P-glycoprotein-like transporter in Leishmania: a search for reversal agents.
    Pérez-Victoria JM; Di Pietro A; Barron D; Ravelo AG; Castanys S; Gamarro F
    Curr Drug Targets; 2002 Aug; 3(4):311-33. PubMed ID: 12102602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydro-beta-agarofuran sesquiterpenes: a new class of reversal agents of the multidrug resistance phenotype mediated by P-glycoprotein in the protozoan parasite Leishmania.
    Cortés-Selva F; Jiménez IA; Munoz-Martínez F; Campillo M; Bazzocchi IL; Pardo L; Ravelo AG; Castanys S; Gamarro F
    Curr Pharm Des; 2005; 11(24):3125-39. PubMed ID: 16178749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemosensitizers in drug transport mechanisms involved in protozoan resistance.
    Pradines B; Pagès JM; Barbe J
    Curr Drug Targets Infect Disord; 2005 Dec; 5(4):411-31. PubMed ID: 16535862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alkyl-lysophospholipid resistance in multidrug-resistant Leishmania tropica and chemosensitization by a novel P-glycoprotein-like transporter modulator.
    Pérez-Victoria JM; Pérez-Victoria FJ; Parodi-Talice A; Jiménez IA; Ravelo AG; Castanys S; Gamarro F
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2468-74. PubMed ID: 11502516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters.
    Di Pietro A; Conseil G; Pérez-Victoria JM; Dayan G; Baubichon-Cortay H; Trompier D; Steinfels E; Jault JM; de Wet H; Maitrejean M; Comte G; Boumendjel A; Mariotte AM; Dumontet C; McIntosh DB; Goffeau A; Castanys S; Gamarro F; Barron D
    Cell Mol Life Sci; 2002 Feb; 59(2):307-22. PubMed ID: 11915946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmaniasis: efflux pumps and chemoresistance.
    Leandro C; Campino L
    Int J Antimicrob Agents; 2003 Sep; 22(3):352-7. PubMed ID: 13678842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of drug action and drug resistance in Leishmania as basis for therapeutic target identification and design of antileishmanial modulators.
    Loiseau PM; Bories C
    Curr Top Med Chem; 2006; 6(5):539-50. PubMed ID: 16719806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of multidrug resistance in Plasmodium and Leishmania: detection of P-glycoprotein-like components.
    Grogl M; Martin RK; Oduola AM; Milhous WK; Kyle DE
    Am J Trop Med Hyg; 1991 Jul; 45(1):98-111. PubMed ID: 1678253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.
    Pérez-Tomás R
    Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P-glycoprotein-mediated resistance to chemotherapy in cancer cells: using recombinant cytosolic domains to establish structure-function relationships.
    Di Pietro A; Dayan G; Conseil G; Steinfels E; Krell T; Trompier D; Baubichon-Cortay H; Jault J
    Braz J Med Biol Res; 1999 Aug; 32(8):925-39. PubMed ID: 10454753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Leishmania: role of P glycoprotein in drug resistance and reversion strategies].
    Osorio EJ; Robledo SM; Arango GJ; Muskus CE
    Biomedica; 2005 Jun; 25(2):242-60. PubMed ID: 16022379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SAR studies of dihydro-beta-agarofuran sesquiterpenes as inhibitors of the multidrug-resistance phenotype in a Leishmania tropica line overexpressing a P-glycoprotein-like transporter.
    Cortés-Selva F; Campillo M; Reyes CP; Jiménez IA; Castanys S; Bazzocchi IL; Pardo L; Gamarro F; Ravelo AG
    J Med Chem; 2004 Jan; 47(3):576-87. PubMed ID: 14736239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmania amazonensis: multidrug resistance in vinblastine-resistant promastigotes is associated with rhodamine 123 efflux, DNA amplification, and RNA overexpression of a Leishmania mdr1 gene.
    Gueiros-Filho FJ; Viola JP; Gomes FC; Farina M; Lins U; Bertho AL; Wirth DF; Lopes UG
    Exp Parasitol; 1995 Dec; 81(4):480-90. PubMed ID: 8542989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of suboptimal doses of inhibitors targeting different domains of LtrMDR1 efficiently overcomes resistance of Leishmania spp. to Miltefosine by inhibiting drug efflux.
    Pérez-Victoria JM; Cortés-Selva F; Parodi-Talice A; Bavchvarov BI; Pérez-Victoria FJ; Muñoz-Martínez F; Maitrejean M; Costi MP; Barron D; Di Pietro A; Castanys S; Gamarro F
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3102-10. PubMed ID: 16940108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional expression of a multidrug P-glycoprotein transporter of Leishmania.
    Cortés-Selva F; Muñoz-Martínez F; Iliás A; Jiménez AI; Váradi A; Gamarro F; Castanys S
    Biochem Biophys Res Commun; 2005 Apr; 329(2):502-7. PubMed ID: 15737615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bis-pyranobenzoquinones as a new family of reversal agents of the multidrug resistance phenotype mediated by P-glycoprotein in mammalian cells and the protozoan parasite Leishmania.
    Jiménez-Alonso S; Pérez-Lomas AL; Estévez-Braun A; Muñoz Martinez F; Chávez Orellana H; Ravelo AG; Gamarro F; Castanys S; López M
    J Med Chem; 2008 Nov; 51(22):7132-43. PubMed ID: 18954040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celastraceae sesquiterpenes as a new class of modulators that bind specifically to human P-glycoprotein and reverse cellular multidrug resistance.
    Muñoz-Martínez F; Lu P; Cortés-Selva F; Pérez-Victoria JM; Jiménez IA; Ravelo AG; Sharom FJ; Gamarro F; Castanys S
    Cancer Res; 2004 Oct; 64(19):7130-8. PubMed ID: 15466210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sitamaquine overcomes ABC-mediated resistance to miltefosine and antimony in Leishmania.
    Pérez-Victoria JM; Bavchvarov BI; Torrecillas IR; Martínez-García M; López-Martín C; Campillo M; Castanys S; Gamarro F
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3838-44. PubMed ID: 21646479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flavonoid dimers as bivalent modulators for pentamidine and sodium stiboglucanate resistance in leishmania.
    Wong IL; Chan KF; Burkett BA; Zhao Y; Chai Y; Sun H; Chan TH; Chow LM
    Antimicrob Agents Chemother; 2007 Mar; 51(3):930-40. PubMed ID: 17194831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug resistance and P-glycoproteins in parasitic protozoa.
    Ullman B
    J Bioenerg Biomembr; 1995 Feb; 27(1):77-84. PubMed ID: 7629055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.